dihexa fda approval Dihexa Capsules | Research Use

The 25mg formulation is available for patients who have completed at least one month on the standard dose with good tolerance and whose provider determines a higher dose is appropriate

The half-life of 159 to 195 hours means there is some flexibility, a day early or late will not ruin the protocol, but regular weekly timing produces the most stable plasma levels

Discontinuation rates due to side effects reached approximately 10% across all dose levels

Thus, bioavailability will be 100% directly after injection, as the active substance is administered directly into the blood

If you have had difficulty tolerating semaglutide side effects or tirzepatide adverse events , cagrilintide alone may offer a smoother experience